The first stop for professional medicines advice

Supply

38 results

Applied filters

Acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings

Alternatives to transcribing for medicines administration

22 February 2022Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.

Considerations for Mpox (monkeypox) vaccination

30 May 2022Considerations for giving vaccine pre or post exposure during a Mpox incident.

Considerations when prescribing guanfacine

16 November 2023Prescribing guidance for guanfacine to support healthcare professionals during the medicine supply disruption.

Considerations when prescribing modified-release methylphenidate

16 November 2023Guidance on the pharmacokinetic differences between modified-release methylphenidate products and clinical implications.

Guidance on Managing The Sourcing and Supply of Ready-to-Administer Chemotheraphy Doses for the NHS (Yellow Cover)

5 December 2016This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Labelling and packaging of unlicensed medicines (Specials): best practice guidance for the NHS

1 March 2022National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines

Labelling requirements for medicines supplied under a PGD

9 September 2020Advice on the legal labelling requirements for Prescription Only Medicines (POM) and Pharmacy Medicines (P) supplied under a Patient Group Direction

Legal mechanisms to supply and administer medicines to individuals

24 January 2022The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)